Document is current
Any future updates will be listed below
-
Authors
Husni, M. Elaine http://orcid.org/0000-0002-3181-4205
Deodhar, Atul http://orcid.org/0000-0002-2130-1246
Schwartzman, Sergio http://orcid.org/0000-0001-9221-891X
Chakravarty, Soumya D. http://orcid.org/0000-0001-7957-838X
Hsia, Elizabeth C.
Leu, Jocelyn H.
Zhou, Yiying
Lo, Kim H.
Kavanaugh, Arthur http://orcid.org/0000-0001-6942-5830
-
Funding
Funding for this research was provided by:
Janssen Research & Development
- License Information
-
More Information
Article History
Received: 25 June 2021
Accepted: 27 February 2022
First Online: 21 March 2022
Declarations
:
: The GO-FURTHER, GO-VIBRANT, and GO-ALIVE trials were conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki. The protocols were approved by the Institutional Review Boards. All patients gave written informed consent before any study-related procedures were performed.
: Not applicable.
: MEH has received honoraria for participation in advisory boards (AbbVie, Amgen, Bristol Myers Squibb, Eli Lilly, Gilead, Janssen, Novartis, Pfizer, Regeneron, UCB).AD has participated in advisory boards (AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eli Lilly, Galapagos, GlaxoSmithKline, Janssen, Novartis, Pfizer, UCB), received research grants (AbbVie, Eli Lilly, GlaxoSmithKline, Novartis, Pfizer, UCB), and participated in speakers’ bureaus (AbbVie, Eli Lilly, Janssen, Novartis, Pfizer, UCB).SS has received consulting fees, research grants, speakers’ bureau activity, or ownership or partnership (AbbVie, Amgen, Boston Scientific, Crescendo Bioscience, Dermtech, Eli Lilly, Genentech, Gilead Sciences, Janssen, Medtronic, Myriad Genetics, National Psoriasis Foundation, Novartis, Pfizer, Regeneron, Samsung, Sanofi, UCB) and participated in advisory boards (Jubilant, Myriad, Stelexis).AK has received research support and/or consulting fees (AbbVie, Amgen, Bristol Myers Squibb, Eli Lilly, Genentech, Janssen, Merck, Novartis, Pfizer, UCB)SDC is an employee of Janssen Scientific Affairs, LLC, and owns stock in Johnson & Johnson.ECH, JHL, YZ, and KHL are or were employees of Janssen Research & Development, LLC, at the time this work was performed and own stock in Johnson & Johnson.
